Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Ductal, Breast

Explore clinical trials studying Carcinoma, Ductal, Breast. Study availability and eligibility vary by location and protocol.

60 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Ductal, Breast trial results

Active, not recruiting

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

NCT02221999

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Department of Thyroid and Breast Gland Surgery,Shenzhen Longgang Central Hospital Shenzhen, Guangdong, China
  • HanDan Central Hospital Handan, Hebei, China
  • The First Affiliated Hospital of University of South China Hengyang, Hunan, China
  • Department of Thyroid and Breast Surgery, The Affiliated Hospital of Inner Mongolia Medical Collage Hohhot, Inner Mongolia, China
View Trial Details
Active, not recruiting

Radiation Therapy in Treating Women With Early Stage Breast Cancer

NCT00909909

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +15 more
Locations
  • RWJBarnabas Health - Robert Wood Johnson University Hospital Hamilton, New Jersey, United States
  • RWJBarnabas Health - Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset, New Jersey, United States
View Trial Details
Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

NCT03455270

Conditions
Adenocarcinoma, Advanced Breast Cancer, Breast Cancer, +16 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Stanford Women Cancer Center Stanford, California, United States
  • Northwestern University - Feinberg School of Medicine Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View all 15 locations
View Trial Details
Completed

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

NCT05900986

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +16 more
Locations
  • Integro Theranostics Research Site #2 Scottsdale, Arizona, United States
  • Integro Theranostics Research Site #12 Washington D.C., District of Columbia, United States
  • Integro Theranostics Research Site #9 Weston, Florida, United States
  • Integro Theranostics Research Site #6 The Bronx, New York, United States
View Trial Details

Related conditions